Regeneron COVID-19 therapy cuts deaths among patients who lack antibodies, study shows

This translation has been automatically generated and has not been verified for accuracy.Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail reduces deaths in hospitalized patients who have not mounted their own antibody response, a large British study published on Wednesday found.

There was no discernible effect of the treatment on those who had generated natural antibody responses and were seropositive. There were 9,785 patients hospitalized with COVID-19 who were randomly allocated to receive usual care plus the antibody combination therapy or just usual care, of which 30 per cent were seronegative.The RECOVERY trial also showed the steroid dexamethasone and Roche’s arthritis drug Actemra cut deaths in hospitalized patients.

Studies also show hydroxycholorquine and ivermectin are cures but there is no money in that

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

British PM Boris Johnson delays plans to lift COVID-19 restrictions until July 19The British Prime Minister cited the spread of the highly transmissible Delta variant as the reason behind the move to delay lifting restrictions Delaying is what the governing class do best. I recall it being 'dithering'
Source: globeandmail - 🏆 5. / 92 Read more »

COVID-19 depleted staff at Quebec long-term care home where 100 died, inquest hearsHead of the regional health authority in Laval said the CHSLD Ste-Dorothee was missing its senior staff, most of whom had been infected by COVID-19
Source: globeandmail - 🏆 5. / 92 Read more »

Quebec long-term care homes free of COVID-19 as 105 new cases reported in provinceNo new or active cases of COVID-19 in Quebec’s long-term care homes as the province surpassed one million second doses
Source: globeandmail - 🏆 5. / 92 Read more »